patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
KIRP-AL-3468	MET Amplification	MET	Crizotinib	199	1624	106	631	24.738	58.372	90.106	25.537	55.528	104.041	0.878	33754.0
KIRP-AL-3468	MET Amplification	MET Copy Number	Crizotinib	117	1706	60	677	24.822	57.83	90.407	25.427	55.769	103.133	0.928	20454.0
KIRP-AL-3468	MET Amplification	MET Copy Number Amplification	Crizotinib	82	1741	42	695	18.828	59.826	100.235	25.554	55.702	102.28	0.59	15317.0
KIRP-AL-3468	BARD1 p.S704R (Missense)	BARD1	Olaparib	80	1743	46	716	95.795	174.51	231.0	74.41	162.973	327.719	0.161	14441.0
KIRP-AL-3468	BARD1 p.S704R (Missense)	BARD1 Somatic Variant	Olaparib	57	1766	34	728	112.029	147.025	150.312	75.237	164.447	328.479	0.404	11329.0
KIRP-AL-3468	BARD1 p.S704R (Missense)	BARD1 Somatic Variant Missense	Olaparib	46	1777	24	738	83.526	142.065	154.777	75.933	164.372	326.644	0.542	8209.0
KIRP-AL-3468	BARD1 p.S704R (Missense)	BARD1 Somatic Variant Missense p.S704R	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
